Compare Tata India Pharma & Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.12
1.86
NAV
₹29.72
₹37.96
Fund Started
04 Dec 2015
25 Jun 2018
Fund Size
₹1239.57 Cr
₹6658.41 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
1 Year
7.35%
8.03%
3 Year
23.57%
27.09%
5 Year
15.33%
16.93%
Equity
99.10%
97.60%
Cash
0.90%
2.37%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.31% |
Max Healthcare Institute Ltd. | 6.24% |
Abbott India Ltd. | 5.98% |
Divi's Laboratories Ltd. | 5.37% |
Healthcare Global Enterprises Ltd. | 5.14% |
Apollo Hospitals Enterprise Ltd. | 4.97% |
Cipla Ltd. | 4.69% |
Rainbow Children's Medicare Ltd. | 3.75% |
Mankind Pharma Ltd. | 3.38% |
Bayer CropScience Ltd. | 3.34% |
Sun Pharmaceutical Industries Ltd. | 11.20% |
Cipla Ltd. | 9.43% |
Dr. Reddy's Laboratories Ltd. | 7.27% |
Mankind Pharma Ltd. | 6.34% |
Divi's Laboratories Ltd. | 6.22% |
Biocon Ltd. | 5.85% |
Lupin Ltd. | 4.80% |
Aurobindo Pharma Ltd. | 3.91% |
Syngene International Ltd. | 2.99% |
Alkem Laboratories Ltd. | 2.90% |
Name
-
-
Start Date
-
-
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
04 Dec 2015
25 Jun 2018
